Results 71 to 80 of about 346 (112)

Molecular Mechanisms of Islet Amyloid Polypeptide Aggregation: Towards Chemical Strategies to Prevent Amyloid Formation and to Design Non-Aggregating Peptide Therapeutics. [PDF]

Int J Mol Sci
Bousch C, Bérubé F, Babych M, Ongeri S, Bourgault S.   +4 more
europepmc   +1 more source

Amylin: From Mode of Action to Future Clinical Potential in Diabetes and Obesity. [PDF]

Diabetes Ther
Volčanšek Š, Koceva A, Jensterle M, Janež A, Muzurović E.   +4 more
europepmc   +1 more source

Amylin, Another Important Neuroendocrine Hormone for the Treatment of Diabesity. [PDF]

Int J Mol Sci
Eržen S, Tonin G, Jurišić Eržen D, Klen J.   +3 more
europepmc   +1 more source

Lipid-Dependent Activation of the Orphan G Protein-Coupled Receptor, GPR3. [PDF]

Biochemistry
Russell IC, Zhang X, Bumbak F, McNeill SM, Josephs TM, Leeming MG, Christopoulos G, Venugopal H, Flocco MM, Sexton PM, Wootten D, Belousoff MJ.   +11 more
europepmc   +1 more source

Evolving Approaches for Pharmacological Therapy of Obesity. [PDF]

Annu Rev Pharmacol Toxicol
Chao AM, Taylor S, Moore M, Amaro A, Wadden TA.   +4 more
europepmc   +1 more source

Jennifer Roberts Design Miami, CEO [PDF]

, 2021
Elman,, Skinner,
core   +1 more source

Amylin - Its role in the homeostatic and hedonic control of eating and recent developments of amylin analogs to treat obesity. [PDF]

Mol Metab, 2018
Boyle CN, Lutz TA, Le Foll C.
europepmc   +1 more source

Structural and dynamic features of cagrilintide binding to calcitonin and amylin receptors. [PDF]

Nat Commun
Cao J, Belousoff MJ, Johnson RM, Keov P, Mariam Z, Deganutti G, Christopoulos G, Hick CA, Reedtz-Runge S, Glendorf T, Ballarín-González B, Raun K, Bayly-Jones C, Wootten D, Sexton PM.   +14 more
europepmc   +1 more source

Thermogenesis in Adipose Tissue: Adrenergic and Non-Adrenergic Pathways. [PDF]

Cells
Hossain MA, Poojari A, Rabiee A.
europepmc   +1 more source